Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Miles Meredith, M.D.,Ph.D.

Concepts

This page shows the publications David Meredith has written about Proto-Oncogene Proteins.
Connection Strength

0.123
  1. Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features. J Neuropathol Exp Neurol. 2019 04 01; 78(4):305-314.
    View in: PubMed
    Score: 0.075
  2. Mapping the minimal domain of hMSH-2 sufficient for binding mismatched oligonucleotides. Biochem Biophys Res Commun. 1997 Mar 06; 232(1):10-3.
    View in: PubMed
    Score: 0.016
  3. Mutational analysis of the nucleotide binding domain of the mismatch repair enzyme hMSH-2. Biochem Biophys Res Commun. 1996 Dec 04; 229(1):147-53.
    View in: PubMed
    Score: 0.016
  4. A carboxy terminal domain of the hMSH-2 gene product is sufficient for binding specific mismatched oligonucleotides. Biochem Biophys Res Commun. 1996 Aug 05; 225(1):289-95.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.